US NATIONAL SURVEY OF PHYSICIAN PRACTICES FOR THE SECONDARY AND TERTIARY PREVENTION OF ISCHEMIC STROKE - DESIGN, SERVICE AVAILABILITY, AND COMMON PRACTICES

被引:62
作者
GOLDSTEIN, LB
BONITO, AJ
MATCHAR, DB
DUNCAN, PW
DEFRIESE, GH
ODDONE, EZ
PAUL, JE
AKIN, DR
SAMSA, GP
机构
[1] DUKE UNIV, CTR HLTH POLICY RES & EDUC, DEPT MED, DURHAM, NC USA
[2] DUKE UNIV, DEPT MED, DIV GEN INTERNAL MED, DURHAM, NC USA
[3] DEPT VET AFFAIRS MED CTR, CTR HLTH SERV RES PRIMARY CARE, DURHAM, NC USA
[4] DEPT VET AFFAIRS MED CTR, DIV NEUROL, DURHAM, NC USA
[5] RES TRIANGLE INST, RES TRIANGLE PK, NC 27709 USA
[6] UNIV N CAROLINA, CECIL G SHEPS CTR HLTH SERV RES, CHAPEL HILL, NC USA
关键词
ANTICOAGULANTS; ASPIRIN; CAROTID ENDARTERECTOMY; DIAGNOSIS; STROKE PREVENTION;
D O I
10.1161/01.STR.26.9.1607
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose Stroke is largely a preventable disease. However, there are little data available concerning the use of stroke prevention diagnostic and treatment modalities by practicing physicians. These data are critical for the rational allocation of resources and targeting of educational efforts. The purposes of this national survey were to gather information about physicians' stroke prevention practice patterns and their attitudes and beliefs regarding secondary and tertiary stroke prevention strategies. Methods We conducted a national survey of stroke prevention practices among a stratified random sample of 2000 physicians drawn from the American Medical Association's Physician Masterfile. The survey focused on the availability of services and the use of diagnostic and preventive strategies for patients at elevated risk of stroke. Besults Sixty-seven percent (n=1006) of eligible physicians completed the survey. Diagnostic studies considered readily available by at least 90% of physicians included carotid ultrasonography, transthoracic echocardiography, Holter monitoring, and brain CT and MRI scans. MR angiography was perceived as being readily available by 68% and transesophageal echocardiography by 74% of respondents. Twelve percent of physicians reported cerebral arteriography and 10% reported carotid endarterectomy as not being readily available. Multiple logistic regression analyses showed that the availability of services varied with physician specialty (noninternist primary care, internal medicine, neurology, surgery), practice setting (nonmetropolitan versus small metropolitan or large metropolitan areas), and for carotid endarterectomy, region of the country (South, Central, Northeast, and West). The odds of carotid endarterectomy being reported as readily available were approximately 2.5 to 3.5 times greater for physicians practicing in the central, northeastern, and western regions compared with those practicing in the South, independent of practice setting and specialty. With regard to stroke prevention practices, 61% of physicians reported prescribing 325 mg of aspirin for stroke prevention, while 33% recommend less than 325 mg and 4% use doses of 650 mg or more. Seventy-one percent of physicians using warfarin reported monitoring anticoagulation with international normalized ratios. and 78% reported monitoring anticoagulated patients at least once a month. Fewer than 20% of physicians reported knowing the perioperative carotid endarterectomy complication rates at the hospital where they perform the operation themselves or refer patients to have the procedure done. Conclusions Although all routine and most specialized services for secondary and tertiary stroke prevention are readily available to most physicians, variation in availability exists. The use of international normalized ratios for monitoring warfarin therapy has not yet become universal. Physician knowledge of carotid endarterectomy complication rates is generally lacking. Depending on their causes, these problems may be addressed through targeted physician education efforts and systematic changes in the way in which services are provided.
引用
收藏
页码:1607 / 1615
页数:9
相关论文
共 45 条
[1]   LOW-DOSE VERSUS HIGH-DOSE ASPIRIN IN PREVENTION OF ISCHEMIC STROKE [J].
ADAMS, HP ;
BENDIXEN, BH .
CLINICAL NEUROPHARMACOLOGY, 1993, 16 (06) :485-500
[2]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[3]  
BALAS P, 1991, INT ANGIOL, V10, P213
[5]  
BARNETT HJM, 1990, STROKE, V21, P40
[6]   CHANGING PATTERNS IN THE PRACTICE OF CAROTID ENDARTERECTOMY IN A LARGE METROPOLITAN-AREA [J].
BROTT, TG ;
LABUTTA, RJ ;
KEMPCZINSKI, RF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (19) :2609-2612
[7]  
Bussey H I, 1993, Heart Dis Stroke, V2, P388
[8]   LOW-DOSE ASPIRIN AND STROKE - IT AINT NECESSARILY SO [J].
DYKEN, ML ;
BARNETT, HJM ;
EASTON, JD ;
FIELDS, WS ;
FUSTER, V ;
HACHINSKI, V ;
NORRIS, JW ;
SHERMAN, DG .
STROKE, 1992, 23 (10) :1395-1399
[9]   THE PERFORMANCE OF ENDARTERECTOMY FOR DISEASE OF THE EXTRACRANIAL ARTERIES OF THE HEAD [J].
DYKEN, ML ;
POKRAS, R .
STROKE, 1984, 15 (06) :948-950
[10]   STROKE AND MORTALITY-RATE IN CAROTID ENDARTERECTOMY - 228 CONSECUTIVE OPERATIONS [J].
EASTON, JD ;
SHERMAN, DG .
STROKE, 1977, 8 (05) :565-568